NCT02103660View on ClinicalTrials.gov

Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected Women

PHASE4CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

April 8, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
HIVContraception
Interventions
DRUG

Depo-Medroxyprogesterone Acetate

150 mg Depo-Medroxyprogesterone Acetate administered every 13 weeks

DRUG

Progestin Contraceptive (Jadelle)

2 implants containing 75 mg of levonorgestrel will be implanted and will last for up to 5 years

Trial Locations (1)

Unknown

UNC-Project Lilongwe, Lilongwe

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Fogarty International Center of the National Institute of Health

NIH

collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

United States Agency for International Development (USAID)

FED

lead

Centers for Disease Control and Prevention

FED

NCT02103660 - Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected Women | Biotech Hunter | Biotech Hunter